The Secret Science To Harnessing the Power of Probiotics using Prebiotics

 

Whether you prefer yogurt, kimchi, kefir, or kombucha, probiotics are all around us. But how do we really harness the benefits of this good bacteria, and capitalize on consuming foods that keep us healthy? The answer — Prebiotics.

Tackling the science, consumer habits, and marketing behind prebiotics in this episode of the MarketScale Sciences Podcast are scientists John Davidson, Director of Innovation & Education for Deerland Probioics & Enzymes, and John Deaton, VP of Science & Technology for Deerland Probiotics & Enzymes. This episode talks about how and why it is important to prime your gut with prebiotics, in order to truly harness the power of probiotics. From a marketing standpoint “probiotics were first out of the gate,” Deaton says, “but it’s not as simple as consuming a probiotic.”

John Davidson says

Probiotic organisms are not very shelf-stable, nor very resilient to our stomach acids. This is why a prebiotic is so important. As non-living organisms, prebiotics are a food source or a compound, and much easier to manage in application. But, for real efficacy, prebiotics must be consumed in large doses. Herein lies the crux that Deerland has tackled head-on.

How do we provide a prebiotic that is small, consumable, and reduces the main side effect of gas, caused by fermentation in the gut? Davidson explains the groundbreaking science of their prebiotic, which is “based on bacteria phase technology.” Davidson and Deaton have reduced the dosage of necessary prebiotics from over 1 gram, to “Only 15 mg a day required for efficacy.”

In short, Deerland has “Really revolutionized the whole prebiotic space.” Says Davidson. The science is in, but the hard work isn’t over. “Consumer education is gonna be the key,” says Davidson. Consumers may love the idea of probiotics, but don’t know that their efforts are futile without the symbiotic help of prebiotics.

Luckily, the probiotic and prebiotic markets are only growing, with business owners taking note of this health phenomenon. Deerland Probiotics & Enzymes is ready with their prebiotic solution, PreforPro.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

What the Future Looks Like if We Get It Right
What the Future Looks Like if We Get It Right
December 30, 2025

As the Patient Monitoring series concludes, the conversation shifts from today’s challenges to tomorrow’s possibilities. This final episode of the five-part Health and Life Sciences at the Edge series looks ahead to what healthcare could become if patient monitoring gets it right. Intel’s Kaeli Tully is joined by Sudha Yellapantula, Senior Researcher at Medical…

Read More
data center infrastructure
AI Is Forcing a Rethink of Data Center Infrastructure at Every Level
December 29, 2025

The data center industry is being redefined by AI’s demand for faster, denser, and more scalable infrastructure. According to McKinsey, average rack power densities have more than doubled in just two years. It went from approximately 8 kW to 17 kW, and is expected to hit 30 kW by 2027. Global data center power demand is projected…

Read More
Emergency department
How Predictive AI Is Helping Hospitals Anticipate Admissions and Optimize Emergency Department Throughput
December 24, 2025

Emergency departments across the U.S. are under unprecedented strain, with overcrowding, staffing shortages, and inpatient bed constraints converging into a throughput crisis. The American Hospital Association reports that hospital capacity and workforce growth have lagged, intensifying delays from arrival to disposition. At the same time, advances in artificial intelligence are moving from experimental to operational—raising…

Read More
Mission
Why Is the Mission of Benchmark So Important
December 23, 2025

As pharmaceutical innovation accelerates, the margin for error narrows, making quality assurance not just a regulatory necessity but a public good. Benchmark’s mission sits at the intersection of progress and protection—helping manufacturers stay aligned with FDA standards so life-saving therapies reach patients faster and safer. By keeping cleanrooms compliant and companies out of trouble, Benchmark…

Read More